Market Snapshot

BSE Sensex: 74339.44 0.66%
BSE 500: 32929.34 0.65%
BSE 200: 10302.32 0.66%
BSE 100: 23658.03 0.65%
BSE Mid-Cap: 41247.11 0.71%
BSE Small-Cap: 47112.78 0.54%
BANKEX: 54993.86 0.71%
BSE IT Sector: 34385.72 0.32%
Nifty 50: 22570.35 0.75%
Nifty 500: 20867.9 0.66%
Nifty 200: 12599.7 0.66%
Nifty 100: 23329.8 0.70%
Nifty Midcap 100: 50228.5 0.47%
Nifty Small 100: 16886.8 0.84%
Nifty IT: 33554.45 0.33%
Nifty PSU Bank: 7403.15 3.77%

News:

Laurus Lab slides after Q4 PAT...
Vedanta PAT slides 27% YoY to ...
Inox Wind hits record high as ...
Glenmark Life drops after Q4 P...
Kotak Mahindra Bank Ltd leads ...

Themis Medicare Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

Invest

25 Apr 2024 | 04:03 PM

210.15

0.65 (0.31%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Outperforms Index

36.93%

Return (1Y)

Beaten Nifty 50 by 10.67%
More Volatile

3.09%

Standard Deviation (1Y)

Higher than Nifty 50 by 2.46%
Consistent Performer

7/12

Months

beaten Nifty 50
AxisDirect View

No View

52 Week High-Low

264

133

News & Announcements

Themis Medicare consolidated net profit declines 44.63% in the December 2023 quarter
75 days ago

Themis Medicare consolidated net profit declines 44.63% in the December 2023 quarter

10 - Feb - 2024 12:00 AM | 75 days ago

Net profit of Themis Medicare declined 44.63% to Rs 7.37 crore in the quarter ended December 2023 as against Rs 13.31 crore during the previous quarter ended December 2022. Sales declined 7.06% to Rs 82.51 crore in the quarter ended December 2023 as against Rs 88.78 crore during the previous quarter ended December 2022.
Particulars Quarter Ended
Dec. 2023 Dec. 2022 % Var.
Sales 82.51 88.78 -7
OPM % 9.77 17.20 -
PBDT 11.31 20.17 -44
PBT 8.22 17.50 -53
NP 7.37 13.31 -45
Powered by Capital Market - Live News
Themis Medicare announces board meeting date
86 days ago

Themis Medicare announces board meeting date

30 - Jan - 2024 12:00 AM | 86 days ago

Themis Medicare will hold a meeting of the Board of Directors of the Company on 10 February 2024.
Powered by Capital Market - Live News
Themis Medicare launches novel Opioid Injectable Analgesic REMIFENTANIL
166 days ago

Themis Medicare launches novel Opioid Injectable Analgesic REMIFENTANIL

10 - Nov - 2023 12:00 AM | 166 days ago

Themis Medicare announced the launch of a novel Opioid Injectable Analgesic REMIFENTANIL under its brand name REMITHEM®in the Indian market for use during induction of anesthesia, during immediate post operative period and in monitored anesthesia care.
Remifentanil® was first approved in USA in 1996 and has wide clinical usage & acceptance around the world in major markets including USA, Europe, Japan and other countries and is also well published.
Powered by Capital Market - Live News
Themis Medicare consolidated net profit declines 36.33% in the September 2023 quarter
173 days ago

Themis Medicare consolidated net profit declines 36.33% in the September 2023 quarter

04 - Nov - 2023 12:00 AM | 173 days ago

Net profit of Themis Medicare declined 36.33% to Rs 11.32 crore in the quarter ended September 2023 as against Rs 17.78 crore during the previous quarter ended September 2022. Sales rose 15.14% to Rs 104.78 crore in the quarter ended September 2023 as against Rs 91.00 crore during the previous quarter ended September 2022.
Particulars Quarter Ended
Sep. 2023 Sep. 2022 % Var.
Sales 104.78 91.00 15
OPM % 11.84 23.46 -
PBDT 17.03 25.19 -32
PBT 13.96 22.63 -38
NP 11.32 17.78 -36
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

FII shareholding in Themis Medicare Ltd has increased by 124.83% since past 3 Months
MF shareholding in Themis Medicare Ltd has increased by 33.33% since past 3 Months
FII shareholding in Themis Medicare Ltd has decreased by -43.6% since past 1 Year
MF shareholding in Themis Medicare Ltd has increased by 33.33% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Dec. 2023	Dec. 2022	% Var.
Sales	82.51	88.78	-7
OPM %	9.77	17.20	-
PBDT	11.31	20.17	-44
PBT	8.22	17.50	-53
NP	7.37	13.31	-45

Particulars	Quarter Ended
	Sep. 2023	Sep. 2022	% Var.
Sales	104.78	91.00	15
OPM %	11.84	23.46	-
PBDT	17.03	25.19	-32
PBT	13.96	22.63	-38
NP	11.32	17.78	-36

General Notifications

My Notifications

Research Notifications

Themis Medicare Ltd Share Price – NSE / BSE Pharmaceuticals, Small Cap

210.15 0.65 (0.31%)

News & Announcements

Price vs Volume

Stock Trivia

Themis Medicare Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

210.15

0.65 (0.31%)